CHTP has trouble recruiting the required 118 patients in Study 302. The original timeline to report data from both Study 301 and Study 302 has slipped from 2Q09 to 3Q09. YE08 cash $36M with a questimate 2009 burn of $40M means CHTP need to dilute common shares for a raise.